{"id":14608,"date":"2021-05-11T07:30:00","date_gmt":"2021-05-11T07:30:00","guid":{"rendered":"https:\/\/eodishasamachar.com\/en\/2021\/05\/11\/fluxergy-announces-improved-clinical-performance-of-its-ce-ivd-covid-19-pcr-test\/"},"modified":"2021-05-11T07:30:00","modified_gmt":"2021-05-11T07:30:00","slug":"fluxergy-announces-improved-clinical-performance-of-its-ce-ivd-covid-19-pcr-test","status":"publish","type":"post","link":"https:\/\/eodishasamachar.com\/en\/2021\/05\/11\/fluxergy-announces-improved-clinical-performance-of-its-ce-ivd-covid-19-pcr-test\/","title":{"rendered":"Fluxergy Announces Improved Clinical Performance of Its CE-IVD COVID-19 PCR Test"},"content":{"rendered":"<p> \n<\/p>\n<div id=\"\"><!--<a class=\"format-txt\" href=\"{baseURL}\/View\/{release.id}?_download=1\">View this article in .txt format<\/a>--><\/p>\n<p>IRVINE, CA. &#8211;\u00a0News Aktuell &#8211;\u00a011 May 2021 &#8211;\u00a0<a href=\"http:\/\/www.fluxergy.com\/\">Fluxergy, Inc.<\/a>, a U.S. medical diagnostic&#13;<br \/>\npoint-of-care platform company with a detection technology solution capable of&#13;<br \/>\nmultiplexity and multimodality, is further announcing improved clinical&#13;<br \/>\nperformance of its CE-IVD COVID-19 RT-PCR test. The CE marking for its one-hour&#13;<br \/>\nCOVID-19 Test Kit allows healthcare professionals to use its <i>in vitro<\/i>&#13;<br \/>\ndiagnostics (IVD) assay for the detection of SARS-CoV-2. Fluxergy&#8217;s innovative&#13;<br \/>\ntesting platform is approved for IVD use in the European Union market and any&#13;<br \/>\nother markets that accept CE marking as valid regulatory approval. <\/p>\n<p style=\"text-align: center\"><img src=\"https:\/\/release.media-outreach.com\/release.php\/Images\/Thumb\/500x0\/149451\/image.jpg#image-149451\" width=\"500\"\/><\/p>\n<h5 style=\"text-align: center\">The Fluxergy Diagnostic System: The Fluxergy Analyzer, which conducts the testing; the Fluxergy Card, a single-use test cartridge and its reagents; and the FluxergyWorks software, to manage the test data. The Fluxergy Test Kit COVID-19 is only available for purchase in the European Union market and any other markets that accept the CE-marking as valid regulatory approval. COURTESY: FLUXERGY, INC.<\/h5>\n<p>&#13;<br \/>\n&#13; <\/p>\n<p>\u00a0<\/p>\n<p>&#13;<br \/>\n&#13; <\/p>\n<p>The&#13;<br \/>\nsimple workflow of the Fluxergy platform allows for a NP swab sample collected&#13;<br \/>\nin a VTM or UTM vial and mixed with the Fluxergy Reaction Mixture within three&#13;<br \/>\nminutes. This can then be immediately loaded onto the Fluxergy Card and&#13;<br \/>\ninserted into the Fluxergy Analyzer for qualitative real-time PCR results&#13;<br \/>\nwithin one hour. The platform is ideal for rapid testing applications such as&#13;<br \/>\nemergency testing and delivery ward testing, as well as community reopening testing&#13;<br \/>\nwhere expedited turnaround times are critical. <\/p>\n<p>&#13;<br \/>\n&#13; <\/p>\n<p>\u00a0<\/p>\n<p>&#13;<br \/>\n&#13; <\/p>\n<p>In&#13;<br \/>\nthe most recent clinical performance comparison study conducted by Fluxergy using ninety-five U.S. clinical specimens collected from November 2020&#13;<br \/>\nto March 2021, the COVID-19 Fluxergy Test Kit was 100% concordant with&#13;<br \/>\nCepheid&#8217;s Xpert Xpress SARS-CoV-2 (the gold standard for COVID-19 RT-PCR at the&#13;<br \/>\nPoint-of-Care, approved for CE-IVD and other regions).<\/p>\n<p>&#13;<br \/>\n&#13; <\/p>\n<p>\u00a0<\/p>\n<\/p><\/div>\n\n<br \/><a href=\"https:\/\/www.media-outreach.com\/news\/2021-05-11\/77596\/fluxergy-announces-improved-clinical-performance-of-its-ce-ivd-covid-19-pcr-test\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, CA. &#8211;\u00a0News Aktuell &#8211;\u00a011 May 2021 &#8211;\u00a0Fluxergy, Inc., a U.S. medical diagnostic&#13; point-of-care platform company with a detection technology solution capable of&#13; multiplexity and multimodality, is further announcing improved clinical&#13; performance of its CE-IVD COVID-19 RT-PCR test. The CE marking for its one-hour&#13; COVID-19 Test Kit allows healthcare professionals to use its in vitro&#13; &hellip;<\/p>\n","protected":false},"author":1,"featured_media":14609,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[60],"tags":[],"_links":{"self":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/14608"}],"collection":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/comments?post=14608"}],"version-history":[{"count":0,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/14608\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media\/14609"}],"wp:attachment":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media?parent=14608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/categories?post=14608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/tags?post=14608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}